The Annonaceous acetogeninnext term bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells
Purchase the full-text article
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Nicholas H. Oberlies, Vicki L. Croy, Marietta L. Harrison and Jerry L. McLaughlinCorresponding Author Contact Information, E-mail The Corresponding Author
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907-1333, USA
Received 19 December 1996;
Revised 14 January 1997;
accepted 14 January 1997.
Available online 15 December 1997.
Abstract
Cytotoxic effects of the previous termAnnonaceous acetogenin,next term bullatacin, were studied in multidrug-resistant (MDR) human mammary adenocarcinoma (MCF-7/Adr) cells vs. the parental non-resistant wild type (MCF-7/wt) cells. Bullatacin was effectively cytotoxic to the MCF-7/Adr cells while it was more cytostatic to the MCF-7/wt cells. ATP depletion is the mode of action of the previous termAnnonaceous acetogenins,next term and these agents offer a special advantage in the chemotherapeutic treatment of MDR tumors that have ATP-dependent mechanisms.
Corresponding author. Tel.: +1 317 4941455; fax: +1 317 4941414.